EP regimen

Jump to navigation Jump to search

WikiDoc Resources for EP regimen


Most recent articles on EP regimen

Most cited articles on EP regimen

Review articles on EP regimen

Articles on EP regimen in N Eng J Med, Lancet, BMJ


Powerpoint slides on EP regimen

Images of EP regimen

Photos of EP regimen

Podcasts & MP3s on EP regimen

Videos on EP regimen

Evidence Based Medicine

Cochrane Collaboration on EP regimen

Bandolier on EP regimen

TRIP on EP regimen

Clinical Trials

Ongoing Trials on EP regimen at Clinical Trials.gov

Trial results on EP regimen

Clinical Trials on EP regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on EP regimen

NICE Guidance on EP regimen


FDA on EP regimen

CDC on EP regimen


Books on EP regimen


EP regimen in the news

Be alerted to news on EP regimen

News trends on EP regimen


Blogs on EP regimen


Definitions of EP regimen

Patient Resources / Community

Patient resources on EP regimen

Discussion groups on EP regimen

Patient Handouts on EP regimen

Directions to Hospitals Treating EP regimen

Risk calculators and risk factors for EP regimen

Healthcare Provider Resources

Symptoms of EP regimen

Causes & Risk Factors for EP regimen

Diagnostic studies for EP regimen

Treatment of EP regimen

Continuing Medical Education (CME)

CME Programs on EP regimen


EP regimen en Espanol

EP regimen en Francais


EP regimen in the Marketplace

Patents on EP regimen

Experimental / Informatics

List of terms related to EP regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:EP Regimen; Etoposide-Platinol Regimen; VP Regimen


EP regimen refers to a regimen consisting of etoposide and cisplatin(Platinol) used to treat small cell[1] and advanced-stage non-small cell lung cancer; also used for the treatment of advanced-stage testicular cancer.[2]


EEtoposide (Vepesid)

PCisplatin (Platinol)



  1. 1.0 1.1 Hanna N, Bunn PA, Langer C, Einhorn L, Guthrie T, Beck T; et al. (2006). "Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer". J Clin Oncol. 24 (13): 2038–43. doi:10.1200/JCO.2005.04.8595. PMID 16648503.
  2. "NCI Thesaurus".
  3. "NCI Thesaurus".